tiprankstipranks
Eupraxia Pharmaceuticals (EPRX)
NASDAQ:EPRX
Holding EPRX?
Track your performance easily

Eupraxia Pharmaceuticals (EPRX) Financial Statements

3 Followers

Eupraxia Pharmaceuticals Financial Overview

Eupraxia Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $-0.919; its P/E ratio is -3.71; Eupraxia Pharmaceuticals is scheduled to report earnings on April 1, 2025, and the estimated EPS forecast is $-0.14. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24Dec 23Sep 23Jun 23
Income Statement-
Total Revenue-----
Gross Profit-----
EBITC$ -5.79MC$ -5.83MC$ -9.67MC$ -6.11MC$ -2.01M
EBITDAC$ -5.75MC$ -5.79MC$ -9.66MC$ -6.07MC$ -1.96M
Net Income Common StockholdersC$ -6.01MC$ -6.04MC$ -9.12MC$ -6.31MC$ -2.44M
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsC$ 23.32MC$ 35.91MC$ 19.34MC$ 33.21MC$ 19.10M
Total AssetsC$ 24.98MC$ 36.64MC$ 20.27MC$ 34.35MC$ 20.35M
Total DebtC$ 4.66MC$ 9.56MC$ 10.45MC$ 198.76KC$ 239.96K
Net DebtC$ -18.66MC$ -26.35MC$ -8.89MC$ -33.01MC$ -18.86M
Total LiabilitiesC$ 11.64MC$ 18.53MC$ 19.37MC$ 19.29MC$ 14.66M
Stockholders EquityC$ 14.83MC$ 19.54MC$ 2.22MC$ 17.04MC$ 7.44M
Cash Flow-
Free Cash FlowC$ -7.69MC$ -6.13MC$ -919.82KC$ -7.96MC$ -5.70M
Operating Cash FlowC$ -7.71MC$ -6.12MC$ -878.64KC$ -7.95MC$ -5.69M
Investing Cash FlowC$ 17.66KC$ -6.79KC$ -41.18KC$ -12.75KC$ -8.55K
Financing Cash FlowC$ -4.50MC$ 23.15MC$ -7.29MC$ 22.04MC$ 6.01M
Currency in CAD

Eupraxia Pharmaceuticals Earnings and Revenue History

Eupraxia Pharmaceuticals Debt to Assets

Eupraxia Pharmaceuticals Cash Flow

Eupraxia Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis